Life Science REIT PLC
LSE:LABS
Intrinsic Value
Life Science Reit Plc is an investment company, which intends to carry on business as a REIT. The Company’s investment objective is to provide shareholders with a level of total return. [ Read More ]
The intrinsic value of one LABS stock under the Base Case scenario is 60.73 GBX. Compared to the current market price of 39.8 GBX, Life Science REIT PLC is Undervalued by 34%.
Valuation Backtest
Life Science REIT PLC
Run backtest to discover the historical profit from buying and selling LABS stocks based on their intrinsic value.
Analyze the historical link between intrinsic value and market price to make more informed investment decisions.
Fundamental Analysis
Balance Sheet Decomposition
Life Science REIT PLC
| Current Assets | 21m |
| Cash & Short-Term Investments | 14.3m |
| Receivables | 4.3m |
| Other Current Assets | 2.4m |
| Non-Current Assets | 389.7m |
| Long-Term Investments | 382.3m |
| Other Non-Current Assets | 7.4m |
| Current Liabilities | 14.4m |
| Accounts Payable | 8.9m |
| Accrued Liabilities | 1.8m |
| Other Current Liabilities | 3.7m |
| Non-Current Liabilities | 112.5m |
| Long-Term Debt | 107.9m |
| Other Non-Current Liabilities | 4.6m |
Earnings Waterfall
Life Science REIT PLC
|
Revenue
|
19.9m
GBP
|
|
Cost of Revenue
|
-6.1m
GBP
|
|
Gross Profit
|
13.8m
GBP
|
|
Operating Expenses
|
-5.2m
GBP
|
|
Operating Income
|
8.6m
GBP
|
|
Other Expenses
|
-30.3m
GBP
|
|
Net Income
|
-21.7m
GBP
|
Free Cash Flow Analysis
Life Science REIT PLC
LABS Profitability Score
Profitability Due Diligence
Life Science REIT PLC's profitability score is 42/100. The higher the profitability score, the more profitable the company is.
Score
Life Science REIT PLC's profitability score is 42/100. The higher the profitability score, the more profitable the company is.
LABS Solvency Score
Solvency Due Diligence
Life Science REIT PLC's solvency score is 53/100. The higher the solvency score, the more solvent the company is.
Score
Life Science REIT PLC's solvency score is 53/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
LABS Price Targets Summary
Life Science REIT PLC
According to Wall Street analysts, the average 1-year price target for LABS is 61.88 GBX with a low forecast of 45.45 GBX and a high forecast of 84 GBX.
Shareholder Return
LABS Price
Life Science REIT PLC
| Average Annual Return | -13.63% |
| Standard Deviation of Annual Returns | 19.98% |
| Max Drawdown | -64% |
| Market Capitalization | 139.3m GBX |
| Shares Outstanding | 350 000 000 |
| Percentage of Shares Shorted | 59% |
Company Profile
Country
Industry
Market Cap
Dividend Yield
Description
Life Science Reit Plc is an investment company, which intends to carry on business as a REIT. The Company’s investment objective is to provide shareholders with a level of total return. The company will seek to achieve its investment objective by investing in a diversified portfolio of properties across the United Kingdom which are leased or intended to be leased to tenants operating in, or providing a benefit to, the life science sector. The company acquires or develops properties, such as wet and dry laboratories, offices, incubators and co-working space, manufacturing and testing facilities and data centers. The company acquires individual buildings, a group of buildings across a single science park or the entirety of a science park. This may include purchasing or developing buildings that are leased or intended to be leased to tenants providing ancillary services to employees of companies operating in, or providing a benefit to, the life science sector. The Company’s investment adviser is Ironstone Asset Management Limited.
Officers
The intrinsic value of one LABS stock under the Base Case scenario is 60.73 GBX.
Compared to the current market price of 39.8 GBX, Life Science REIT PLC is Undervalued by 34%.
You don't have any saved screeners yet
